Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients by Negri, M. et al.
Examination of Potential Virulence Factors of Candida
tropicalis Clinical Isolates From Hospitalized Patients
Melyssa Negri • Margarida Martins •
Mariana Henriques • Terezinha I. E. Svidzinski •
Joana Azeredo • Rosa´rio Oliveira
Received: 27 July 2009 / Accepted: 3 October 2009 / Published online: 23 October 2009
 Springer Science+Business Media B.V. 2009
Abstract Candida tropicalis has been reported to be
one of the Candida species which is most likely to
cause bloodstream and urinary tract infections in
hospitalized patients. Accordingly, the aim of this
study was to characterize the virulence of C. tropicalis
by assessing antifungal susceptibility and comparing
the expression of several virulence factors. This study
was conducted with seven isolates of C. tropicalis from
urine and blood cultures and from central venous
catheter. C. tropicalis ATCC 750 was used as reference
strain. Yeasts adhered (2 h) to epithelial cells and
silicone and 24 h biofilm biomass were determined by
crystal violet staining. Pseudohyphae formation ability
was determined after growth in fetal bovine serum.
Enzymes production (hemolysins, proteases, phospho-
lipases) was assessed by halo formation on agar
plates. Susceptibility to antifungal agents was determined
by E-test. Regarding adhesion, it can be highlighted
that C. tropicalis strains adhered significantly
more to epithelium than to silicone. Furthermore, all
C. tropicalis strains were able to form biofilms and to
express total hemolytic activity. However, protease
was only produced by two isolates from urine and by
the isolates from catheter and blood. Moreover, only
one C. tropicalis (from catheter) was phospholipase
positive. All isolates were susceptible to voriconazole,
fluconazole and amphotericin B. Four strains were
susceptible-dose dependent to itraconazole and one
clinical isolate was found to be resistant.
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Introduction
Fungal hospital infections (FHI) incidence has
increased significantly over the last decades. Candida
species are the most frequently isolated fungi,
corresponding to approximately 80% of FHI, being
the fourth responsible for blood stream infection and
the overwhelming majority responsible for urinary
tract infections [1–3].
Usually, Candida tropicalis is considered the third
Candida species most frequently isolated from urine
cultures [4, 5]. Moreover, in a recent epidemiological
study conducted in 12 Brazilian medical centers,
C. tropicalis was the second most frequent Candida
species, accounting for 20–24% of all candidemias
[2, 6]. Additionally, C. tropicalis is often found in
patients admitted in intensive care units (ICUs),
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especially in patients with cancer or/and requiring
prolonged catheterization, or receiving broad-spec-
trum antibiotics [2, 4, 6, 7].
Several virulence factors seem to be responsible for
C. tropicalis infections, which present high potential
for dissemination and mortality [8, 9]. Adhesion to
host surfaces (epithelial cells and medical devices), as
well as biofilm formation, are considered the first step
to initiate Candida infection [10, 11]. Furthermore,
secretion of enzymes (proteases and phospholipases),
as well as hemolytic activity, are recognized as
important factors in tissue invasion [10–14].
Hence, the aim of this study was to assess and
compare the expression of different virulence factors
(enzymes secretion, adhesion and biofilm formation
and pseudohyphae production) by several C. tropicalis
clinical isolates. Moreover, antifungal susceptibility
was also determined in order to deeply characterize the
virulence of C. tropicalis.
Materials and Methods
Isolates
This study was conducted with seven isolates of
C. tropicalis: five obtained from candiduria, one from
candidemia and one from a central venous catheter
(CVC) and all were from patients admitted to ICUs at
the University Hospital (UH) in Maringa´, Parana´,
Brazil. C. tropicalis ATCC 750 was used as reference
strain.
Isolation and Identification
Yeasts were isolated according to hospital routine
methods. To perform hemoculture, one volume of
blood was inoculated in 10 volumes of Trypticase Soy
Broth (Difco, Detroit, Michigan, EUA) and incubated
in the automatic BACTEC (Becton–Dickinson Micro-
biology Systems, Sparks, MD) system. Urine was
spread using a calibrated loop (10 ll) on CLED
medium agar plates (Difco) and incubated at 37C for
48 h. CVC isolated yeasts underwent a well estab-
lished technique [15]. Briefly, CVC was rolled on
blood agar plates (Difco) and incubated at 35C for
72 h. After yeast growth, they were subcultured in
CHROMagar Candida (CHROMagar, BioMerieux,
Paris, France) to assess the purity of the culture and the
color of the colonies. From this selective and differ-
ential medium, yeasts were identified by three meth-
ods: the MicroScan rapid yeast identification panel
(Dade Behring Inc, CA, USA), the classical biochem-
ical method [16] and molecular identification.
Candida DNA was extracted using the QIAamp
DNA Mini Kit (QIAGEN, IZASA, Lisboa, Portugal)
according to the manufacturer’s instructions. DNA
content was determined by spectrophotometry read-
ings at 260 nm. Aliquots of 10 ll were analyzed by
electrophoresis in a 0.8% agarose (Bio-Rad, Lisboa,
Portugal) gel in 19 TBE buffer (Bio-Rad) and
visualized with a UV transilluminator after ethidium
bromide (Bio-Rad) staining (0.5 mg/ml). To assess
Candida speciation, a polymerase chain reaction
(PCR) method previously described [17] was used.
Specific primers for the genomic sequences of DNA
topoisomerase II of C. albicans, C. dubliniensis,
C. tropicalis (genotypes I and II), C. parapsilosis
(genotypes I and II), C. krusei, C. kefyr, C. guilliermondii
and C. glabrata were used.
Adhesion and Biofilm Formation
Yeast cells were grown at 37C, 120 rpm for 18 h on
Sabouraud Dextrose Broth (SDB; Difco) and Phos-
phate saline buffer (PBS)—washed suspensions of
each yeast culture were resuspended in RPMI 1640
(Sigma, Saint Louis, Missouri, USA) to a final
concentration of 1.0 9 107 cells/ml. Then, 3 ml of
the suspension was added to each well of a 6-well plate
containing either a confluent layer of TCC-SUP human
urinary bladder epithelial cell line (DSMZ—German
Collection of Microorganisms and Cell Cultures) or a
silicone coupon (2 9 2 cm) (Neves e Neves, Trofa,
Portugal). All procedures were performed in triplicate
and repeated in three separate assays.
Quantification of Adhered Yeast Cells
After 2 h of incubation (120 rpm, at 37C), the wells
were washed twice with PBS to remove unattached
yeasts. Yeast cells were quantified using the crystal
violet (CV) staining method.
Epithelial Cells
Three milliliters of CV stain (1%) was added to each
well containing the epithelial cells with adherent
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yeasts and allowed to stain for 5 min. Then, the wells
were washed three times with PBS. In order to
remove the CV stain from the epithelial cells, 3 ml of
ethanol:acetone (1:1) was added to each well and
removed immediately. Three milliliter of acetic acid
(33%) was added to each well and the absorbance of
the final solution was read at 570 nm in a microtitre
plate reader (Bio-Tek Synergy HT, IZASA). Wells
containing epithelial cells without yeasts were used
as controls. The mean absorbance of CV retained by
yeasts was expressed as absorbance per unit of well
area.
Silicone
Candida cells adhered to silicone were quantified
according to Henriques et al. [18]. Briefly, the coupons
containing adherent yeasts were removed from each
well and immersed for 5 min in new well plates
containing 3 ml of methanol. After withdrawing the
methanol, the coupons were allowed to dry at room
temperature. Then, 3 ml of CV (1%) was added to each
well and allowed to stain for 5 min. Coupons were
transferred to a new well, washed with ultrapure water
and immersed in 3 ml acetic acid (33%) to dissolve the
stain. Coupons without yeasts were used as controls.
The absorbance of the obtained solution was read in
triplicate in a microtitre plate reader at 570 nm. The
final number of cells attached, per coupon unit area,
was determined using the mean absorbance and the
respective calibration curves, previously established.
Biofilm Biomass Quantification
After 24 h of incubation (120 rpm, at 37C) C. trop-
icalis biofilm forming ability was assessed on inert
materials through quantification of total biomass by
CV staining as described above. Experiments were
repeated in 3–5 independent assays.
Pseudohyphae Formation
Pseudohyphae formation was defined as a cell
bearing a rounded outgrowth with a length greater
than or equal to the diameter of the parent cell, with a
constriction at the base. The percentage of cells in
pseudohyphae form, against blastospores, was deter-
mined by microscopy counting after 2 h of cell
growth in a liquid medium containing equal volumes
of RPMI 1640 (Sigma) and fetal bovine serum
(GIBCO, New York, USA). In these experiments,
100 cells per field were examined. Each experiment
was conducted in triplicate.
Protease and Phospholipase Secretion
Secretion of proteases and phospholipases was
detected by the formation of an opaque halo of
degradation around the colonies grown in a specific
agar plate, according to Ru¨chel [19] and Price et al.
[20], respectively. An aliquot (5 ll) of a 1 9 108
cells/ml suspension prepared in distilled water was
inoculated on protease agar medium (2% agar, 1.17%
yeast carbon base, 0.01% yeast extract and 0.2%
bovine serum albumin) pH 5.0 and on phospholipase
agar (2% agar, 1% peptone, 2% glucose, 1 M NaCl,
5 mM CaCl22H2O and 8% egg yolk) and the Petri
dishes were incubated for 7 days at 37C. The
enzymatic activity (Pz) was determined by the ratio
between the colony diameter and the colony diameter
plus the halo zone as described by Price et al. [20].
Each experiment was conducted in triplicate.
Hemolytic Activity
Hemolysin production was evaluated using a modi-
fication of the plate assay described by Luo et al.
[13]. Fresh cultured colonies of C. tropicalis were
obtained after being spread on Sabouraud Dextrose
Agar (SDA; Difco) (18–24 h). Then, a suspension
was prepared in saline solution (0.9% NaCl) to reach
108 cells/ml, enumerated using a Neubauer chamber.
Ten microliters of this suspension was spot-inocu-
lated on sugar-enriched sheep blood (2% peptone, 1%
agar, 7% fresh sheep blood, 3% glucose) and the
plates were incubated at 37C. After 48 h they were
classified as absent (no halo), partial, or total
(completely transparent halo) hemolytic activity.
The assay was conducted in quadruplicate on two
separate occasions for each yeast isolate tested. A
standard strain, C. albicans ATCC 90028, was used
as control in each experiment.
Antifungal Susceptibility Test Methods
The E-test method was used as recommended by the
manufacturer with strips, provided by AB BIODISK
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(Solna, Sweden), having the following concentrations:
from 0.002 to 256 lg/ml; for fluconazole (FLU) and
from 0.002 to 32 lg/ml for itraconazole (ITR),
voriconazole (VO) and amphotericin B (AMB). The
minimum inhibitory concentrations (MIC) of drugs
were determined on RPMI 1640 (Sigma) agar with 2%
glucose. An inoculum suspension was adjusted to a
turbidity of 0.5 McFarland standard (1 9 106 to
5 9 106 cells/ml) and was incubated at 37C for
48 h. MICs were read as the lowest concentration at
which the border of the elliptical inhibition zone
intercepted the scale on the strip. Quality control was
performed in accordance with the Clinical and Lab-
oratory Standards Institute (CLSI) document M27-A3
[21], using Candida krusei ATTC 6258 and C.
parapsilosis ATCC 22019. MIC interpretative criteria
was performed according to the CLSI M27-A3 [21]:
(a) FLU: MIC B 8 lg/ml—susceptible (S); 16\ MIC
\ 32 lg/ml—susceptible-dose dependent (S-DD) and
MIC C 64 lg/ml—resistant (R); (b) ITR: MIC B
0.125 lg/ml—S; 0.25\MIC\0.5 lg/ml—S-DD and
MIC C 1 lg/ml—R; (c) AMB MIC [ 1 lg/ml—R;
(d) VO MIC C 1 lg/ml—S; B 2 lg/ml—R.
Statistical Analysis
Results obtained were analyzed using the SPSS
(Statistical Package for the Social Sciences) program.
One-way ANOVA with the Bonferroni test was used
to compare the number of adherent cells of the
several strains assayed. All tests were performed with
a confidence level of 95%.
Results
A total of seven C. tropicalis isolates was used in this
study: five obtained from urine samples, one from
blood samples and one from CVC, all from patients
admitted to ICUs at the UH of Maringa´, Parana´,
Brazil. Additionally, all the methods (MicroScan
rapid yeast identification panel, classical biochemical
and molecular identification) used had identified
C. tropicalis with 100% concordance (data not shown).
Regarding adhesion ability (Fig. 1), it can be
highlighted that all C. tropicalis adhered in a
significantly greater extent (P \ 0.05) to epithelial
cells than to silicone. Considering the differences
among the isolates, it is possible to observe from
Fig. 1 that C. tropicalis L012, from CVC, adhered in
a highest extent to epithelial cells (4.05 9 106 cells/cm2)
with P \ 0.001 vs. strains 1, 16, 29, 69 and to
silicone (9.37 9 105 cells/cm2) with P \ 0.001 vs.
strains 1, 12, 69. Clinical isolates 29 and 69, from
urine cultures, adhered to epithelial cells in lower
number than other yeasts (P \ 0.05 vs. L012) and the
latter, as well as strain 12, adhered in lower extent
than other yeasts to silicone (Fig. 1).
As it can be observed in Fig. 2, all C. tropicalis
were able to form biofilms and strains did not present
significant statistical differences.
Fig. 1 Number of C. tropicalis cells per cm2 (no cell/cm2)
(mean ± standard deviation) adhered to TCC-SUP epithelial
cells and to silicone measured by crystal violet staining.
* represents the statistical differences (P \ 0.05) of adhesion
extension to TCC-SUP between the strain L012 and strains 1,
16, 29, 69, ATCC 750; ** represents the statistical differences
(P \ 0.05) of adhesion extension to silicone of the strains 16
and 1 compared to the strains 29, 75, L012, ATCC 750
Fig. 2 Biofilm biomass on silicone measured by crystal violet
staining, expressed as absorbance (570 nm)/cm2 [Abs (570 nm)/cm2].
Mean ± standard deviation
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Concerning C. tropicalis pseudohyphae formation
and enzymatic activity (Table 1), it was possible to
verify that all isolates produced a low percentage of
pseudohyphae formation. Among all, isolates 12 and
L012 presented the highest production of pseudo-
hyphae formation (10 and 7%, respectively). Never-
theless, all isolates were able to express total
hemolytic activity on sheep-blood agar medium
supplemented with glucose. However, protease was
only produced by two isolates from urine and by the
isolates from catheter and blood and only one
C. tropicalis (from CVC) was phospholipase positive.
The levels of C. tropicalis isolates antifungal
susceptibility are shown in Table 2. It is possible to
observe that all isolates showed susceptibility (S) to
VO, FLU and AMB. The largest percent of S-DD was
observed for ITR in four strains and one clinical isolate
from urine was found to be resistant (MIC = 1 lg/ml).
Discussion
Nosocomial infections by Non-Candida albicans
Candida (NCAC) species such as candidemia and
candiduria have emerged as an increasing problem
during the last two decades [22, 23]. Moreover,
C. tropicalis appears to display higher potential for
dissemination and mortality and possesses several
virulence factors that can enhance the progression of
infections than C. albicans and other NCAC species
[6, 8, 24].
In the present study, the results of morphological
and biochemical tests were in agreement with
molecular identification. Morphological, serological,
or biochemical tests have been used, along the years,
for the identification of Candida species. However,
misidentification has been reported specially in
relation to C. tropicalis [3, 10]. Recently, molecu-
lar-based techniques, which are simpler and more
efficient than the conventional tests, have been
adapted to the identification of pathogenic microor-
ganisms. In particular, due to its speed, reproducibil-
ity, high sensitivity and specificity, PCR tests have
been increasingly used in laboratories for identifica-
tion of several fungal species [3, 10, 17].
Concerning adhesion ability, it was possible to
verify that all C. tropicalis adhered in a significantly
higher extent (P \ 0.05) to epithelial cells than to
silicone. Sohn et al. [25] compared the ability of
C. albicans to adhere to the human colorectal
carcinoma cell line Caco-2 and epidermoid vulvo-
vaginal A431 cells and to polystyrene and reported
that C. albicans adheres in high extent to polystyrene
and both epithelia. According to Bendel and Hostetter
[26], the extent of adhesion to the human epithelial
cell line HeLa S3 did not differ between C. albicans
and C. tropicalis despite both species having distinct
Table 1 Comparison of putative virulence factors of C. tropi-
calis from clinical isolate, including proteolytic (Pro), phos-
pholytic (Phos) and hemolysis (Hemo) activity and ability for
pseudohyphae formation
Isolates Activity Pseudohyphae
formation
Sites Strain Proa Phosa Hemo %
Urine 12 1.00 1.00 Total 10
Urine 16 0.81 1.00 Total 4
Urine 29 0.85 1.00 Total 3
Urine 75 1.00 1.00 Total 4
Urine 69 1.00 1.00 Total 1
CVC L012 0.89 0.66 Total 7
Blood 1 0.69 1.00 Total 2
a Values of enzyme activity, according to Price et al. [20]:
Pz = 1.00 means that the test strain is negative for enzymtic
activity, while a value of Pz \ 1.00 means that the test strain is
positive for enzyme activity
Table 2 In vitro
susceptibility of
C. tropicalis from clinical
isolates for amphotericin B
(AMB), voriconazole (VO),
itraconazole (ITR) and
fluconazole (FLU)
a MIC interpretative
criteria was performed
according to the CLSI
M27-A3 [21]
Isolates Susceptibility category (MIC lg/ml)a
Sites Strain AMB VO ITR FLU
Urine 12 S (0.5) S (0.032) S (0.064) S (0.5)
Urine 16 S (0.25) S (0.032) S-DD (0.38) S (0.5)
Urine 29 S (0.38) S (0.023) SDD (0.38) S (0.5)
Urine 75 S (1) S (0.064) SDD (0.5) S (0.125)
Urine 69 S (0.125) S (0.125) R (1) S (2)
CVC L012 S (0.003) S (0.023) SDD (0.25) S (1)
Blood 1 S (0.047) S (0.012) S (0.032) S (0.25)
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mechanisms for this process. Nevertheless, the pres-
ent results clearly show differences in the adhesion
ability among the different isolates and hence adhe-
sion of C. tropicalis to biotic and abiotic surfaces is
strain dependant. Different intra-species adherence
ability was also reported by other authors for other
Candida species [9, 27–29].
We did not find a clear relation between pseudo-
hyphae formation and adhesion capability. Although
C. tropicalis L012, from CVC, and strain 12, from
urine, adhered in higher extent to epithelial cells
presenting also more pseudohyphae formation, the
strain 75 exhibited an intermediate pseudohyphae
formation and high adhesion ability. On the other
hand, clinical isolates 29 and 69, from urine cultures,
adhered to epithelial cells and displayed pseudohyp-
hae formation in a lower extent than the other strains.
This evidences the current lack of knowledge
concerning the adhesion mechanisms of NCAC
species to epithelium, as well as about the factors
affecting the adhesion process [18].
Adhesion of Candida spp. to hard materials or host
cells has been considered as an early step in biofilm
formation [30, 31]. Nevertheless, it is important to
highlight that, although strains 69 and 12 adhered in
small number than other yeasts to silicone (Fig. 1)
they showed higher ability to form biofilms on this
material (Fig. 2). This result is consistent with other
studies [14, 32], reporting differences between adhe-
sion and biofilm formation abilities on polysterene
and poly(vinyl chloride) (PVC) surfaces under static
conditions, which also suggest that adhesion and
biofilm formation of C. tropicalis are two distinct
phenomena.
All C. tropicalis strains tested were able to form
biofilms on silicone, which has important clinical
impact once biofilm-associated infections are difficult
to treat, representing a source of reinfections [23, 33].
Previous works also reported that C. tropicalis can
form extensive in vitro biofilms in PVC catheters [34]
and polystyrene surfaces [33].
The infective ability of yeasts depends on specific
virulence mechanisms that confer the ability to
colonize host surfaces, to invade deeper host tissue
or to evade host defences [8, 35, 36]. During the
pathogenic process many virulence attributes may be
involved including production of extracellular prote-
ases and phospholipases, as well as hemolytic activity
[10–14, 37, 38]. In this study, all isolates were able to
express total hemolytic activity. Manns et al. [12]
demonstrated that C. albicans produced hemolytic
activity and Luo et al. [13] observed that NCAC
species are capable of producing one or more types of
hemolysins in vitro with differences among species.
Moreover, they observed that C. tropicalis was able
to produce complete hemolysis after 48 h, corrobo-
rating the results obtained herein.
In the present case, only few isolates were protease
and phospholipase positive, corroborating the results
of other authors [10, 39]. In opposition, Kumar et al.
[38] detected 100 and 72.9% of proteases and phos-
pholipase producers, respectively, among Candida
spp. isolated from pulmonary tuberculosis patients.
According to these results, protease and phospholipase
expression can vary according to Candida species,
strain and the site of isolation. Furthermore, although
the methods used to test the presence of these enzymes
are simple and fast they are not excessively accurate,
specially compared with molecular methods that can
detect gene expression [24, 36].
Concerning antifungal susceptibility results, all
isolates were susceptible to VO, FLU and AMB and
for four strains were S-DD for ITR. However, one
clinical isolate showed to be resistant to ITR. These
results are comparable to those reported in the
literature, with slight differences that were dependent
on the underlying disease and the Candida species
involved in the infection [10, 14, 40, 41].
Though some authors have already assessed some
C. tropicalis virulence factors, this work gathers, for
the first time, the most important ones: secretion of
enzymes, pseudohyphae formation, adhesion (to epithe-
lial cells and silicone), biofilm formation and anti-
fungal susceptibility. Despite it was not possible to
establish a relation among the virulence factors
assayed, it is interesting to notice that the strain
isolated from CVC (L012) presented higher levels of
all these factors. Furthermore, all clinical isolates
presented one or more virulence factors.
References
1. Lundstrom T, Sobel J. Nosocomial candiduria: a review.
Clin Infect Dis. 2001;32:1602–7. doi:10.1086/320531.
2. Colombo AL, Nucci M, Park BJ, Noue´r SA, Arthington-
Skaggs B, da Matta DA, et al. Epidemiology of candidemia
in Brazil: a nationwide sentinel surveillance of candidemia
180 Mycopathologia (2010) 169:175–182
123
in eleven medical centers. J Clin Microbiol. 2006;44:2816–
23. doi:10.1128/JCM.00773-06.
3. Asmundsdottir LR, Erlendsdottir H, Haraldsson G, Guo H,
Xu J, Gottfredsson M. Molecular epidemiology of candi-
demia: evidence of clusters of smoldering nosocomial
infections. Clin Infect Dis. 2008;47:17–24. doi:10.1086/58
9298.
4. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA,
McKinsey DS, Karchmer AW, et al. Prospective multicenter
surveillance study of funguria in hospitalized patients. Clin
Infect Dis. 2000;30:14–8. doi:10.1086/313583.
5. A´lvarez-Lerma F, Nolla-Salas J, Leo´n C, Palomar M, Jorda´
R, Carrasco N, et al. Candiduria in critically ill patients
admitted to intensive care medical units. Intensive Care
Med. 2003;29:1069–76. doi:10.1007/s00134-003-1807-y.
6. Nucci M, Colombo AL. Candidemia due to Candida
tropicalis: clinical, epidemiologic, and microbiologic
characteristics of 188 episodes occurring in tertiary care
hospitals. Diagn Microbiol Infect Dis. 2007;58:77–82. doi:
10.1016/j.diagmicrobio.2006.11.009.
7. Rho J, Shin JH, Song JW, Park MR, Kee SJ, Jang SJ, et al.
Molecular investigation of two consecutive nosocomial
clusters of Candida tropicalis candiduria using pulsed-field
gel electrophoresis. J Microbiol. 2004;42:80–6.
8. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing
fungaemia: pathogenicity and antifungal resistance. J Hosp
Infect. 2002;50:243–60. doi:10.1053/jhin.2001.1151.
9. Okawa Y, Miyauchi M, Kobayashi H. Comparison of
pathogenicity of various Candida tropicalis strains. Biol
Pharm Bull. 2008;31:1507–10.
10. Furlaneto-Maia L, Specian A, Bizerra F, de Oliveira M,
Furlaneto M. In vitro evaluation of putative virulence
attributes of oral isolates of Candida spp. obtained from
elderly healthy individuals. Mycopathologia. 2008;166:
209–17. doi:10.1007/s11046-008-9139-7.
11. Tamura NK, Negri MFN, Bonassoli LA, Svidzinski TIE.
Fatores de viruleˆncia de Candida spp isoladas de cateteres
venosos e ma˜os de servidores hospitalares. Rev Soc Bras
Med Trop. 2007;40:91–3. doi:10.1590/S0037-86822007
000100021.
12. Manns JM, Mosser DM, Buckley HR. Production of a
hemolytic factor by Candida albicans. Infect Immun.
1994;62:5154–6. doi:10.1590/S0037-86822009000200029.
13. Luo G, Samaranayake LP, Yau JYY. Candida species
exhibit differential in vitro hemolytic activities. J Clin
Microbiol. 2001;39:2971–4. doi:10.1128/JCM.39.8.2971-
2974.2001.
14. Bizerra FC, Nakamura CV, de Poersch C, Estivalet Svid-
zinski TI, Borsato Quesada RM, Goldenberg S, et al.
Characteristics of biofilm formation by Candida tropicalis
and antifungal resistance. FEMS Yeast Res. 2008;8:442–
50. doi:10.1111/j.1567-1364.2007.00347.x.
15. Maki DG, Weise CE, Sarafin HW. A semiquantitative
culture method for identifying intravenous-catheter-related
infection. N Engl J Med. 1977;296:1305–9.
16. Kurtzman CP, Fell JW (1998) The yeasts, a taxonomics.
4th ed. Elsevier Science.
17. Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-
based identification of pathogenic Candida species using
primer mixes specific to Candida DNA topoisomerase II
genes. Yeast. 2002;19:973–89. doi:10.1002/yea.892.
18. Henriques M, Azeredo J, Oliveira R. Candida species
adhesion to oral epithelium: factors involved and experi-
mental methodology used. Crit Rev Microbiol. 2006;32:
217–26. doi:10.1080/10408410601023524.
19. Ru¨chel R. Proteinases of pathogenic fungi. Mycoses.
1999;42:48–52.
20. Price M, Wilkinson I, Gentry L. Plate method for detection
of phospholipase activity in Candida albicans. Sabourau-
dia. 1982;20:7–14.
21. Clinical and Laboratory Standards Institute (CLSI). Ref-
erence method for broth dilution antifungal susceptibility
testing of yeasts; approved standard. 3rd edition (M27-A3).
CLSI document M27-A3. Wayne, PA, USA: Clinical and
Laboratory Standards Institute.
22. Lai C-C, Tan C-K, Huang Y-T, Shao P-L, Hsueh P-R. Current
challenges in the management of invasive fungal infections.
J Infect Chemother. 2008;14:77–85. doi:10.1007/s10156-
007-0595-7.
23. Schelenz S. Management of candidiasis in the intensive
care unit. J Antimicrob Chemother. 2008;61:31–4. doi:
10.1093/jac/dkm430.
24. Zaugg C, Borg-von Zepelin M, Reichard U, Sanglard D,
Monod M. Secreted aspartic proteinase family of Candida
tropicalis. Infect Immun. 2001;69:405–12. doi:10.1128/
IAI.69.1.405-412.2001.
25. Sohn K, Senyu¨rek I, Fertey J, Ko¨nigsdorfer A, Joffroy C,
Hauser N, et al. An in vitro assay to study the transcrip-
tional response during adherence of Candida albicans to
different human epithelia. FEMS Yeast Res. 2006;6:1085–
93. doi:10.1111/j.1567-1364.2006.00130.x.
26. Bendel C, Hostetter M. Distinct mechanisms of epithelial
adhesion for Candida albicans and Candida tropicalis.
Identification of the participating ligands and development
of inhibitory peptides. J Clin Invest. 1993;92:1840–9. doi:
10.1172/JCI116775.
27. Panagoda GJ, Ellepola ANB, Samaranayake LP. Adhesion
of Candida parapsilosis to epithelial and acrylic surfaces
correlates with cell surface hydrophobicity. Mycoses.
2001;44:29–35. doi:10.1046/j.1439-0507.2001.00611.x.
28. Lyon PJ, Resende MA. Correlation between adhesion,
enzyme production, and susceptibility to fluconazole in
Candida albicans obtained from denture wearers. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:
632–8. doi:10.1016/j.tripleo.2005.12.015.
29. Henriques M, Azeredo J, Oliveira R. The involvement of
physico-chemical interactions in the adhesion of Candida
albicans and Candida dubliniensis to epithelial cells. Mycoses.
2007;50:391–6. doi:10.1111/j.1439-0507.2007.01387.x.
30. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCor-
mick T, Ghannoum MA. Biofilm formation by the fungal
pathogen Candida albicans: development, architecture,
and drug resistance. J Bacteriol. 2001;183:5385–94. doi:
10.1128/JB.183.18.5385-5394.2001.
31. Douglas LJ. Candida biofilms and their role in infection.
Trends Microbiol. 2003;11:30–6. doi:10.1016/S0966-842X
(02)00002-1.
32. Silva S, Henriques M, Martins A, Oliveira R, Williams D,
Azeredo J. Biofilms of non-Candida albicans Candida
species: quantification, structure and matrix composition.
Med Mycol. 2009;20:1–9. doi:10.1080/136937808025
49594.
Mycopathologia (2010) 169:175–182 181
123
33. Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK,
et al. Biofilm production by isolates of Candida species
recovered from nonneutropenic patients: comparison of
bloodstream isolates with isolates from other sources.
J Clin Microbiol. 2002;40:1244–8. doi:10.1128/JCM.40.4.
1244-1248.2002.
34. Hawser SP, Douglas LJ. Biofilm formation by Candida
species on the surface of catheter materials in vitro. Infect
Immun. 1994;62:915–21.
35. Yang Y. Virulence factors of Candida species. J Microbiol
Immunol Infect. 2003;36:223–8.
36. Fu Y, Luo G, Spellberg BJ, Edwards JE Jr, Ibrahim AS.
Gene overexpression/suppression analysis of candidate
virulence factors of Candida albicans. Eukaryot Cell.
2008;7:483–92. doi:10.1128/EC.00445-07.
37. da Costa K, Ferreira J, Komesu M, Candido R. Candida
albicans and Candida tropicalis in oral candidosis: quan-
titative analysis, exoenzyme activity, and antifungal drug
sensitivity. Mycopathologia. 2009;167:73–9. doi:10.1007/
s11046-008-9154-8.
38. Kumar VG, Latha R, Vedhagiri K, Sathiamoorthi T,
Jayarani G, Sasikala R, et al. Phospholipase C, proteinase
and hemolytic activities of Candida spp. isolated from
pulmonary tuberculosis patients. J Mycol Med. 2009;19:
3–10. doi:10.1016/j.mycmed.2008.11.002.
39. Gokce G, Cerikcioglu N, Yagci A. Acid proteinase,
phospholipase, and biofilm production of Candida species
isolated from blood cultures. Mycopathologia. 2007;164:
265–9. doi:10.1007/s11046-007-9053-4.
40. Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke
P. Activity of voriconazole, itraconazole, fluconazole and
amphotericin B in vitro against 1763 yeasts from 472
patients in the voriconazole phase III clinical studies. Int
J Antimicrob Agents. 2008;32:511–4. doi:10.1016/j.ijanti
micag.2008.05.023.
41. Panizo MM, Revia´kina V, Dolande M, Selgrad S. Candida
spp. in vitro susceptibility profile to four antifungal agents.
Resistance surveillance study in Venezuelan strains. Med
Mycol. 2009;47:137–43. doi:10.1080/13693780802144339
.
182 Mycopathologia (2010) 169:175–182
123
